Copyright Reports & Markets. All rights reserved.

Global Buprenorphine Hydrochloride Tablets Market Research Report 2021

Request for Sample of this report
Buy now

1 Buprenorphine Hydrochloride Tablets Market Overview

  • 1.1 Product Overview and Scope of Buprenorphine Hydrochloride Tablets
  • 1.2 Buprenorphine Hydrochloride Tablets Segment by Type
    • 1.2.1 Global Buprenorphine Hydrochloride Tablets Sales Growth Rate Comparison by Type (2021-2027)
    • 1.2.2 0.5mg
    • 1.2.3 2mg
  • 1.3 Buprenorphine Hydrochloride Tablets Segment by Application
    • 1.3.1 Global Buprenorphine Hydrochloride Tablets Sales Comparison by Application: (2021-2027)
    • 1.3.2 Analgesic
    • 1.3.3 Opioid Antagonist
  • 1.4 Global Buprenorphine Hydrochloride Tablets Market Size Estimates and Forecasts
    • 1.4.1 Global Buprenorphine Hydrochloride Tablets Revenue 2016-2027
    • 1.4.2 Global Buprenorphine Hydrochloride Tablets Sales 2016-2027
    • 1.4.3 Buprenorphine Hydrochloride Tablets Market Size by Region: 2016 Versus 2021 Versus 2027

2 Buprenorphine Hydrochloride Tablets Market Competition by Manufacturers

  • 2.1 Global Buprenorphine Hydrochloride Tablets Sales Market Share by Manufacturers (2016-2021)
  • 2.2 Global Buprenorphine Hydrochloride Tablets Revenue Market Share by Manufacturers (2016-2021)
  • 2.3 Global Buprenorphine Hydrochloride Tablets Average Price by Manufacturers (2016-2021)
  • 2.4 Manufacturers Buprenorphine Hydrochloride Tablets Manufacturing Sites, Area Served, Product Type
  • 2.5 Buprenorphine Hydrochloride Tablets Market Competitive Situation and Trends
    • 2.5.1 Buprenorphine Hydrochloride Tablets Market Concentration Rate
    • 2.5.2 The Global Top 5 and Top 10 Largest Buprenorphine Hydrochloride Tablets Players Market Share by Revenue
    • 2.5.3 Global Buprenorphine Hydrochloride Tablets Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Buprenorphine Hydrochloride Tablets Retrospective Market Scenario by Region

  • 3.1 Global Buprenorphine Hydrochloride Tablets Retrospective Market Scenario in Sales by Region: 2016-2021
  • 3.2 Global Buprenorphine Hydrochloride Tablets Retrospective Market Scenario in Revenue by Region: 2016-2021
  • 3.3 North America Buprenorphine Hydrochloride Tablets Market Facts & Figures by Country
    • 3.3.1 North America Buprenorphine Hydrochloride Tablets Sales by Country
    • 3.3.2 North America Buprenorphine Hydrochloride Tablets Revenue by Country
    • 3.3.3 United States
    • 3.3.4 Canada
  • 3.4 Europe Buprenorphine Hydrochloride Tablets Market Facts & Figures by Country
    • 3.4.1 Europe Buprenorphine Hydrochloride Tablets Sales by Country
    • 3.4.2 Europe Buprenorphine Hydrochloride Tablets Revenue by Country
    • 3.4.3 Germany
    • 3.4.4 France
    • 3.4.5 U.K.
    • 3.4.6 Italy
    • 3.4.7 Russia
  • 3.5 Asia Pacific Buprenorphine Hydrochloride Tablets Market Facts & Figures by Region
    • 3.5.1 Asia Pacific Buprenorphine Hydrochloride Tablets Sales by Region
    • 3.5.2 Asia Pacific Buprenorphine Hydrochloride Tablets Revenue by Region
    • 3.5.3 China
    • 3.5.4 Japan
    • 3.5.5 South Korea
    • 3.5.6 India
    • 3.5.7 Australia
    • 3.5.8 Taiwan
    • 3.5.9 Indonesia
    • 3.5.10 Thailand
    • 3.5.11 Malaysia
  • 3.6 Latin America Buprenorphine Hydrochloride Tablets Market Facts & Figures by Country
    • 3.6.1 Latin America Buprenorphine Hydrochloride Tablets Sales by Country
    • 3.6.2 Latin America Buprenorphine Hydrochloride Tablets Revenue by Country
    • 3.6.3 Mexico
    • 3.6.4 Brazil
    • 3.6.5 Argentina
  • 3.7 Middle East and Africa Buprenorphine Hydrochloride Tablets Market Facts & Figures by Country
    • 3.7.1 Middle East and Africa Buprenorphine Hydrochloride Tablets Sales by Country
    • 3.7.2 Middle East and Africa Buprenorphine Hydrochloride Tablets Revenue by Country
    • 3.7.3 Turkey
    • 3.7.4 Saudi Arabia
    • 3.7.5 UAE

4 Global Buprenorphine Hydrochloride Tablets Historic Market Analysis by Type

  • 4.1 Global Buprenorphine Hydrochloride Tablets Sales Market Share by Type (2016-2021)
  • 4.2 Global Buprenorphine Hydrochloride Tablets Revenue Market Share by Type (2016-2021)
  • 4.3 Global Buprenorphine Hydrochloride Tablets Price by Type (2016-2021)

5 Global Buprenorphine Hydrochloride Tablets Historic Market Analysis by Application

  • 5.1 Global Buprenorphine Hydrochloride Tablets Sales Market Share by Application (2016-2021)
  • 5.2 Global Buprenorphine Hydrochloride Tablets Revenue Market Share by Application (2016-2021)
  • 5.3 Global Buprenorphine Hydrochloride Tablets Price by Application (2016-2021)

6 Key Companies Profiled

  • 6.1 Siegfried
    • 6.1.1 Siegfried Corporation Information
    • 6.1.2 Siegfried Description and Business Overview
    • 6.1.3 Siegfried Buprenorphine Hydrochloride Tablets Sales, Revenue and Gross Margin (2016-2021)
    • 6.1.4 Siegfried Buprenorphine Hydrochloride Tablets Product Portfolio
    • 6.1.5 Siegfried Recent Developments/Updates
  • 6.2 Sanofi
    • 6.2.1 Sanofi Corporation Information
    • 6.2.2 Sanofi Description and Business Overview
    • 6.2.3 Sanofi Buprenorphine Hydrochloride Tablets Sales, Revenue and Gross Margin (2016-2021)
    • 6.2.4 Sanofi Buprenorphine Hydrochloride Tablets Product Portfolio
    • 6.2.5 Sanofi Recent Developments/Updates
  • 6.3 Johnson Matthey
    • 6.3.1 Johnson Matthey Corporation Information
    • 6.3.2 Johnson Matthey Description and Business Overview
    • 6.3.3 Johnson Matthey Buprenorphine Hydrochloride Tablets Sales, Revenue and Gross Margin (2016-2021)
    • 6.3.4 Johnson Matthey Buprenorphine Hydrochloride Tablets Product Portfolio
    • 6.3.5 Johnson Matthey Recent Developments/Updates
  • 6.4 Mallinckrodt
    • 6.4.1 Mallinckrodt Corporation Information
    • 6.4.2 Mallinckrodt Description and Business Overview
    • 6.4.3 Mallinckrodt Buprenorphine Hydrochloride Tablets Sales, Revenue and Gross Margin (2016-2021)
    • 6.4.4 Mallinckrodt Buprenorphine Hydrochloride Tablets Product Portfolio
    • 6.4.5 Mallinckrodt Recent Developments/Updates
  • 6.5 Noramco
    • 6.5.1 Noramco Corporation Information
    • 6.5.2 Noramco Description and Business Overview
    • 6.5.3 Noramco Buprenorphine Hydrochloride Tablets Sales, Revenue and Gross Margin (2016-2021)
    • 6.5.4 Noramco Buprenorphine Hydrochloride Tablets Product Portfolio
    • 6.5.5 Noramco Recent Developments/Updates
  • 6.6 Unichemlabs
    • 6.6.1 Unichemlabs Corporation Information
    • 6.6.2 Unichemlabs Description and Business Overview
    • 6.6.3 Unichemlabs Buprenorphine Hydrochloride Tablets Sales, Revenue and Gross Margin (2016-2021)
    • 6.6.4 Unichemlabs Buprenorphine Hydrochloride Tablets Product Portfolio
    • 6.6.5 Unichemlabs Recent Developments/Updates
  • 6.7 Arevipharma
    • 6.6.1 Arevipharma Corporation Information
    • 6.6.2 Arevipharma Description and Business Overview
    • 6.6.3 Arevipharma Buprenorphine Hydrochloride Tablets Sales, Revenue and Gross Margin (2016-2021)
    • 6.4.4 Arevipharma Buprenorphine Hydrochloride Tablets Product Portfolio
    • 6.7.5 Arevipharma Recent Developments/Updates
  • 6.8 Resonance-labs
    • 6.8.1 Resonance-labs Corporation Information
    • 6.8.2 Resonance-labs Description and Business Overview
    • 6.8.3 Resonance-labs Buprenorphine Hydrochloride Tablets Sales, Revenue and Gross Margin (2016-2021)
    • 6.8.4 Resonance-labs Buprenorphine Hydrochloride Tablets Product Portfolio
    • 6.8.5 Resonance-labs Recent Developments/Updates
  • 6.9 Sun Pharma
    • 6.9.1 Sun Pharma Corporation Information
    • 6.9.2 Sun Pharma Description and Business Overview
    • 6.9.3 Sun Pharma Buprenorphine Hydrochloride Tablets Sales, Revenue and Gross Margin (2016-2021)
    • 6.9.4 Sun Pharma Buprenorphine Hydrochloride Tablets Product Portfolio
    • 6.9.5 Sun Pharma Recent Developments/Updates
  • 6.10 Rusan Pharma
    • 6.10.1 Rusan Pharma Corporation Information
    • 6.10.2 Rusan Pharma Description and Business Overview
    • 6.10.3 Rusan Pharma Buprenorphine Hydrochloride Tablets Sales, Revenue and Gross Margin (2016-2021)
    • 6.10.4 Rusan Pharma Buprenorphine Hydrochloride Tablets Product Portfolio
    • 6.10.5 Rusan Pharma Recent Developments/Updates
  • 6.11 Micro Orgo Chem
    • 6.11.1 Micro Orgo Chem Corporation Information
    • 6.11.2 Micro Orgo Chem Buprenorphine Hydrochloride Tablets Description and Business Overview
    • 6.11.3 Micro Orgo Chem Buprenorphine Hydrochloride Tablets Sales, Revenue and Gross Margin (2016-2021)
    • 6.11.4 Micro Orgo Chem Buprenorphine Hydrochloride Tablets Product Portfolio
    • 6.11.5 Micro Orgo Chem Recent Developments/Updates
  • 6.12 Faranshimi
    • 6.12.1 Faranshimi Corporation Information
    • 6.12.2 Faranshimi Buprenorphine Hydrochloride Tablets Description and Business Overview
    • 6.12.3 Faranshimi Buprenorphine Hydrochloride Tablets Sales, Revenue and Gross Margin (2016-2021)
    • 6.12.4 Faranshimi Buprenorphine Hydrochloride Tablets Product Portfolio
    • 6.12.5 Faranshimi Recent Developments/Updates
  • 6.13 Teva
    • 6.13.1 Teva Corporation Information
    • 6.13.2 Teva Buprenorphine Hydrochloride Tablets Description and Business Overview
    • 6.13.3 Teva Buprenorphine Hydrochloride Tablets Sales, Revenue and Gross Margin (2016-2021)
    • 6.13.4 Teva Buprenorphine Hydrochloride Tablets Product Portfolio
    • 6.13.5 Teva Recent Developments/Updates

7 Buprenorphine Hydrochloride Tablets Manufacturing Cost Analysis

  • 7.1 Buprenorphine Hydrochloride Tablets Key Raw Materials Analysis
    • 7.1.1 Key Raw Materials
    • 7.1.2 Key Suppliers of Raw Materials
  • 7.2 Proportion of Manufacturing Cost Structure
  • 7.3 Manufacturing Process Analysis of Buprenorphine Hydrochloride Tablets
  • 7.4 Buprenorphine Hydrochloride Tablets Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers

  • 8.1 Marketing Channel
  • 8.2 Buprenorphine Hydrochloride Tablets Distributors List
  • 8.3 Buprenorphine Hydrochloride Tablets Customers

9 Buprenorphine Hydrochloride Tablets Market Dynamics

  • 9.1 Buprenorphine Hydrochloride Tablets Industry Trends
  • 9.2 Buprenorphine Hydrochloride Tablets Growth Drivers
  • 9.3 Buprenorphine Hydrochloride Tablets Market Challenges
  • 9.4 Buprenorphine Hydrochloride Tablets Market Restraints

10 Global Market Forecast

  • 10.1 Buprenorphine Hydrochloride Tablets Market Estimates and Projections by Type
    • 10.1.1 Global Forecasted Sales of Buprenorphine Hydrochloride Tablets by Type (2022-2027)
    • 10.1.2 Global Forecasted Revenue of Buprenorphine Hydrochloride Tablets by Type (2022-2027)
  • 10.2 Buprenorphine Hydrochloride Tablets Market Estimates and Projections by Application
    • 10.2.1 Global Forecasted Sales of Buprenorphine Hydrochloride Tablets by Application (2022-2027)
    • 10.2.2 Global Forecasted Revenue of Buprenorphine Hydrochloride Tablets by Application (2022-2027)
  • 10.3 Buprenorphine Hydrochloride Tablets Market Estimates and Projections by Region
    • 10.3.1 Global Forecasted Sales of Buprenorphine Hydrochloride Tablets by Region (2022-2027)
    • 10.3.2 Global Forecasted Revenue of Buprenorphine Hydrochloride Tablets by Region (2022-2027)

11 Research Finding and Conclusion

    12 Methodology and Data Source

    • 12.1 Methodology/Research Approach
      • 12.1.1 Research Programs/Design
      • 12.1.2 Market Size Estimation
      • 12.1.3 Market Breakdown and Data Triangulation
    • 12.2 Data Source
      • 12.2.1 Secondary Sources
      • 12.2.2 Primary Sources
    • 12.3 Author List

    The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

    Segment by Type
    0.5mg
    2mg

    Segment by Application
    Analgesic
    Opioid Antagonist

    By Region
    North America
    United States
    Canada
    Europe
    Germany
    France
    U.K.
    Italy
    Russia
    Asia-Pacific
    China
    Japan
    South Korea
    India
    Australia
    Taiwan
    Indonesia
    Thailand
    Malaysia
    Latin America
    Mexico
    Brazil
    Argentina
    Middle East & Africa
    Turkey
    Saudi Arabia
    UAE

    By Company
    Siegfried
    Sanofi
    Johnson Matthey
    Mallinckrodt
    Noramco
    Unichemlabs
    Arevipharma
    Resonance-labs
    Sun Pharma
    Rusan Pharma
    Micro Orgo Chem
    Faranshimi
    Teva

    Buy now